65岁子宫癌诊断:联邦医疗保险资格起始与医疗补助扩展的影响
这项生态学研究利用监测、流行病学和最终结果(SEER)项目2000至2021年数据,分析55至74岁女性子宫癌发病率。结果显示65岁观察发病率108.2/10万女性年,高于模型预期102.5;该高峰在医疗补助扩展州减弱,未扩展州持续存在,提示保险覆盖影响及时诊断。
要点
- 65岁子宫癌观察发病率为108.2/10万女性年,高于预期102.5。
- 医疗补助扩展州该高峰减弱,未扩展州持续存在。
- 研究提示保险覆盖有助于及时诊断子宫癌。
核心结论
- 65岁联邦医疗保险资格起始与子宫癌诊断高峰相关,医疗补助扩展似可减弱该高峰。
研究设计与样本
- 生态学研究,使用监测、流行病学和最终结果(SEER)项目2000至2021年美国55至74岁女性子宫癌登记数据。
主要发现
- 总体样本中,65岁观察子宫癌发病率为108.2例/10万女性年(95%置信区间106.4至110.1),高于多项式模型预期值102.5(95%置信区间101.4至103.5)。
- 按诊断分期和种族及族裔分层分析,观察到相似模式。
- 65岁发病高峰在《平价医疗法案》后(2014-2021年)医疗补助扩展州减弱,但在未扩展州持续存在。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Uterine cancer, for which diagnosis is based on evaluation of symptoms, most commonly postmenopausal bleeding, is one of the few cancers in the United States with rising incidence and mortality. Inability to access diagnostic services due to lack of insurance coverage may lead to delayed diagnosis and inferior outcomes. OBJECTIVE: The aim of the study was to examine whether the onset of Medicare eligibility at age 65 was associated with a spike in the incidence of uterine cancer and whether this association was attenuated by Medicaid expansion through the Affordable Care Act. STUDY DESIGN: This ecological study used cancer registry data from the Surveillance, Epidemiology, and End Results program to estimate the incidence rate of uterine cancer among women aged 55 to 74 from 2000 to 2021 in the United States. Second order polynomial modeling was used to fit the association between age (in single years) and incidence rate at the population level while excluding age 65 to identify the expected incidence rate at age 65 in the absence of a spike. The expected uterine cancer incidence rate at age 65 was generated from the model and compared to the observed rate at age 65 in the overall sample. Similar analyses were also conducted further stratified by stage, race and ethnicity, pre-Affordable Care Act (2004-2013) versus post-Affordable Care Act (2014-2021) period and states' Medicaid expansion status. RESULTS: In the overall sample, the observed uterine cancer incidence rate at age 65 was 108.2 cases per 100,000 woman-years (95% confidence interval, 106.4 to 110.1), which exceeded the expected rate projected from the polynomial model (102.5; 95% confidence interval, 101.4-103.5). A similar pattern was observed in analysis stratified by stage at diagnosis and by race and ethnicity. The spike in incidence at age 65 diminished in Medicaid expansion states in the post-Affordable Care Act period but persisted in nonexpansion states. CONCLUSION: Onset of Medicare eligibility at age 65 was associated with a spike in uterine cancer diagnoses, which appeared to be mitigated by Medicaid expansion. These findings underscore the importance of insurance coverage in facilitating timely uterine cancer diagnoses.
引用
- Rouse KJ, Chen L, Layne TM, et al. Uterine cancer diagnosis at age 65: onset of Medicare eligibility and impact of Medicaid expansion. Am J Obstet Gynecol. 2025. PMID: 40947084. doi:10.1016/j.ajog.2025.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。